Former Chief Commercial Officer · Amylyx Pharmaceuticals, Inc. (AMLX)

Margaret Olinger

A named executive officer of Amylyx Pharmaceuticals in every fiscal year CompBrief holds from FY2021 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$3,447,150

Salary $488,750Stock awards $618,194

FY2022: $2,995,817

4th of 6 named executive officers at Amylyx Pharmaceuticals by FY2023 total.

6 named officers on file for Amylyx Pharmaceuticals, FY2023

Margaret Olinger’s pay file — $29

  • 3 fiscal years of pay, line by line
  • AMLX’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Amylyx Pharmaceuticals’s whole pay program stands against its peers

  • Amylyx Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AMLX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 24, 2024 (DEF 14A).

Free

Get Margaret Olinger’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Margaret Olinger compensation by year

Amylyx Pharmaceuticals Summary Compensation Table · all 3 fiscal years held
In US dollars, as Amylyx Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023
Salary$372,000$424,337$488,750
Bonus$0$0$0
Stock awards$0$538,327$618,194
Option awards$296,400$1,795,200$1,736,927
Non-equity incentive$186,298$228,803$225,216
Pension and deferred compensation$0$0$0
All other$8,700$9,150$378,063
Total$863,398$2,995,817$3,447,150

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Amylyx Pharmaceuticals, Inc. DEF 14A filed April 24, 2024, accession 0000950170-24-047243, and prior-year filings.

How this page was built: the Amylyx Pharmaceuticals, Inc. filed document, accession 0000950170-24-047243. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2024.

$863K
$3.0M
$3.4M
FY21
FY22
FY23
SalaryNon-equity incentiveStock awardsOption awardsAll other

Amylyx Pharmaceuticals’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Justin KleeCo-Chief Executive Officer and Director$7,418,169
Joshua CohenCo-Chief Executive Officer and Director$7,418,169
James FratesChief Financial Officer$3,510,377
Margaret Olinger · this pageFormer Chief Commercial Officer$3,447,150
Gina MazzarielloChief Legal Officer and General Counsel$3,013,676
Camille BedrosianChief Medical Officer$2,372,859

The full Amylyx Pharmaceuticals compensation record

free company brief

This page is one person within Amylyx Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Amylyx Pharmaceuticals proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Amylyx Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Margaret Olinger's compensation dossier · One-time report. No refunds.